nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—DHCR7—Epirubicin—sarcoma	0.216	0.28	CbGbCtD
Tamoxifen—DHCR7—Doxorubicin—sarcoma	0.115	0.149	CbGbCtD
Tamoxifen—CYP1B1—Mitoxantrone—sarcoma	0.0422	0.0549	CbGbCtD
Tamoxifen—CYP2B6—Thiotepa—sarcoma	0.0328	0.0427	CbGbCtD
Tamoxifen—ABCB11—Vincristine—sarcoma	0.0291	0.0378	CbGbCtD
Tamoxifen—CYP1A1—Dacarbazine—sarcoma	0.0239	0.031	CbGbCtD
Tamoxifen—ABCG2—Dactinomycin—sarcoma	0.0224	0.0291	CbGbCtD
Tamoxifen—ABCG2—Mitoxantrone—sarcoma	0.0201	0.0261	CbGbCtD
Tamoxifen—CYP2E1—Dacarbazine—sarcoma	0.0184	0.024	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—sarcoma	0.0182	0.0236	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—sarcoma	0.0182	0.0236	CbGbCtD
Tamoxifen—ABCC2—Vincristine—sarcoma	0.0153	0.0199	CbGbCtD
Tamoxifen—CYP2E1—Mitoxantrone—sarcoma	0.0143	0.0186	CbGbCtD
Tamoxifen—ABCC2—Etoposide—sarcoma	0.014	0.0182	CbGbCtD
Tamoxifen—ABCG2—Vincristine—sarcoma	0.0138	0.0179	CbGbCtD
Tamoxifen—ABCG2—Etoposide—sarcoma	0.0127	0.0164	CbGbCtD
Tamoxifen—CYP1A2—Dacarbazine—sarcoma	0.0107	0.0139	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0102	0.0133	CbGbCtD
Tamoxifen—CYP3A7—Vincristine—sarcoma	0.0102	0.0133	CbGbCtD
Tamoxifen—CYP3A4—Thiotepa—sarcoma	0.0101	0.0131	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—sarcoma	0.00955	0.0124	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—sarcoma	0.00903	0.0117	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—sarcoma	0.00863	0.0112	CbGbCtD
Tamoxifen—ABCB1—Dactinomycin—sarcoma	0.00809	0.0105	CbGbCtD
Tamoxifen—CYP3A5—Vincristine—sarcoma	0.00765	0.00994	CbGbCtD
Tamoxifen—ABCB1—Mitoxantrone—sarcoma	0.00724	0.0094	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—sarcoma	0.00701	0.00911	CbGbCtD
Tamoxifen—CYP2C8—Etoposide—sarcoma	0.00674	0.00876	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—sarcoma	0.00607	0.00789	CbGbCtD
Tamoxifen—CYP1A2—Etoposide—sarcoma	0.00522	0.00678	CbGbCtD
Tamoxifen—ABCB1—Vincristine—sarcoma	0.00498	0.00647	CbGbCtD
Tamoxifen—ABCB1—Etoposide—sarcoma	0.00456	0.00593	CbGbCtD
Tamoxifen—CYP3A4—Mitoxantrone—sarcoma	0.00434	0.00563	CbGbCtD
Tamoxifen—CES1—larynx—sarcoma	0.00317	0.0474	CbGeAlD
Tamoxifen—ABCB1—Doxorubicin—sarcoma	0.00311	0.00405	CbGbCtD
Tamoxifen—CYP3A4—Vincristine—sarcoma	0.00298	0.00388	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—sarcoma	0.00293	0.00381	CbGbCtD
Tamoxifen—CYP3A4—Etoposide—sarcoma	0.00273	0.00355	CbGbCtD
Tamoxifen—ESR1—periosteum—sarcoma	0.00205	0.0306	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—sarcoma	0.00187	0.00242	CbGbCtD
Tamoxifen—DHCR7—mammary gland—sarcoma	0.00151	0.0225	CbGeAlD
Tamoxifen—FMO1—mammary gland—sarcoma	0.00151	0.0225	CbGeAlD
Tamoxifen—SULT1A1—seminal vesicle—sarcoma	0.00136	0.0203	CbGeAlD
Tamoxifen—SULT1A1—hematopoietic system—sarcoma	0.00129	0.0193	CbGeAlD
Tamoxifen—EBP—uterus—sarcoma	0.00118	0.0176	CbGeAlD
Tamoxifen—UGT1A4—hematopoietic system—sarcoma	0.00112	0.0168	CbGeAlD
Tamoxifen—ESRRA—myometrium—sarcoma	0.00105	0.0157	CbGeAlD
Tamoxifen—DHCR7—seminal vesicle—sarcoma	0.000965	0.0144	CbGeAlD
Tamoxifen—ESRRA—seminal vesicle—sarcoma	0.00095	0.0142	CbGeAlD
Tamoxifen—DHCR7—hematopoietic system—sarcoma	0.000917	0.0137	CbGeAlD
Tamoxifen—EBPL—testis—sarcoma	0.000889	0.0133	CbGeAlD
Tamoxifen—ESR2—mammary gland—sarcoma	0.000889	0.0133	CbGeAlD
Tamoxifen—SULT1A1—tendon—sarcoma	0.000853	0.0128	CbGeAlD
Tamoxifen—EBPL—liver—sarcoma	0.000841	0.0126	CbGeAlD
Tamoxifen—EBP—liver—sarcoma	0.000806	0.012	CbGeAlD
Tamoxifen—DHCR7—skin of body—sarcoma	0.000797	0.0119	CbGeAlD
Tamoxifen—SULT1A1—testis—sarcoma	0.000707	0.0106	CbGeAlD
Tamoxifen—DHCR7—cardiac atrium—sarcoma	0.000696	0.0104	CbGeAlD
Tamoxifen—SIGMAR1—mammary gland—sarcoma	0.000689	0.0103	CbGeAlD
Tamoxifen—ESRRA—cardiac atrium—sarcoma	0.000685	0.0102	CbGeAlD
Tamoxifen—ESRRA—uterus—sarcoma	0.000682	0.0102	CbGeAlD
Tamoxifen—SULT1A1—liver—sarcoma	0.000668	0.00998	CbGeAlD
Tamoxifen—CYP1B1—mammary gland—sarcoma	0.000655	0.00979	CbGeAlD
Tamoxifen—DHCR7—lymphoid tissue—sarcoma	0.000646	0.00965	CbGeAlD
Tamoxifen—EBPL—lymph node—sarcoma	0.000645	0.00963	CbGeAlD
Tamoxifen—CES1—hematopoietic system—sarcoma	0.000626	0.00935	CbGeAlD
Tamoxifen—ESR1—mammary gland—sarcoma	0.000609	0.0091	CbGeAlD
Tamoxifen—FMO1—tendon—sarcoma	0.000607	0.00907	CbGeAlD
Tamoxifen—CES1—connective tissue—sarcoma	0.000602	0.009	CbGeAlD
Tamoxifen—ESRRA—tendon—sarcoma	0.000597	0.00893	CbGeAlD
Tamoxifen—DHCR7—bone marrow—sarcoma	0.000588	0.00879	CbGeAlD
Tamoxifen—UGT1A4—liver—sarcoma	0.000583	0.00871	CbGeAlD
Tamoxifen—ESRRA—bone marrow—sarcoma	0.000579	0.00865	CbGeAlD
Tamoxifen—CYP2A6—seminal vesicle—sarcoma	0.000573	0.00856	CbGeAlD
Tamoxifen—ESR2—hematopoietic system—sarcoma	0.000542	0.0081	CbGeAlD
Tamoxifen—ESR2—connective tissue—sarcoma	0.000522	0.0078	CbGeAlD
Tamoxifen—SULT1A1—lymph node—sarcoma	0.000512	0.00765	CbGeAlD
Tamoxifen—DHCR7—testis—sarcoma	0.000503	0.00751	CbGeAlD
Tamoxifen—CYP2C8—mammary gland—sarcoma	0.000502	0.0075	CbGeAlD
Tamoxifen—ESRRA—testis—sarcoma	0.000495	0.00739	CbGeAlD
Tamoxifen—SIGMAR1—myometrium—sarcoma	0.000489	0.00731	CbGeAlD
Tamoxifen—ESR2—smooth muscle tissue—sarcoma	0.000477	0.00713	CbGeAlD
Tamoxifen—DHCR7—liver—sarcoma	0.000475	0.0071	CbGeAlD
Tamoxifen—FMO1—liver—sarcoma	0.000475	0.0071	CbGeAlD
Tamoxifen—ESRRA—liver—sarcoma	0.000468	0.00699	CbGeAlD
Tamoxifen—CYP2C9—mammary gland—sarcoma	0.000446	0.00666	CbGeAlD
Tamoxifen—SIGMAR1—seminal vesicle—sarcoma	0.000442	0.0066	CbGeAlD
Tamoxifen—CES1—lymphoid tissue—sarcoma	0.000441	0.00658	CbGeAlD
Tamoxifen—ABCB11—testis—sarcoma	0.000439	0.00656	CbGeAlD
Tamoxifen—FMO3—testis—sarcoma	0.000434	0.00649	CbGeAlD
Tamoxifen—ESR1—myometrium—sarcoma	0.000432	0.00646	CbGeAlD
Tamoxifen—CYP19A1—hematopoietic system—sarcoma	0.000427	0.00638	CbGeAlD
Tamoxifen—ESR1—embryo—sarcoma	0.000416	0.00621	CbGeAlD
Tamoxifen—ABCB11—liver—sarcoma	0.000415	0.00621	CbGeAlD
Tamoxifen—CYP19A1—connective tissue—sarcoma	0.000411	0.00614	CbGeAlD
Tamoxifen—FMO3—liver—sarcoma	0.000411	0.00614	CbGeAlD
Tamoxifen—ESR2—uterus—sarcoma	0.000409	0.00612	CbGeAlD
Tamoxifen—CYP3A7—liver—sarcoma	0.000406	0.00607	CbGeAlD
Tamoxifen—CYP1B1—hematopoietic system—sarcoma	0.000399	0.00597	CbGeAlD
Tamoxifen—CYP1B1—connective tissue—sarcoma	0.000384	0.00574	CbGeAlD
Tamoxifen—ESR2—lymphoid tissue—sarcoma	0.000381	0.0057	CbGeAlD
Tamoxifen—ESR1—hematopoietic system—sarcoma	0.000371	0.00555	CbGeAlD
Tamoxifen—SIGMAR1—smooth muscle tissue—sarcoma	0.00037	0.00553	CbGeAlD
Tamoxifen—FMO1—lymph node—sarcoma	0.000364	0.00544	CbGeAlD
Tamoxifen—DHCR7—lymph node—sarcoma	0.000364	0.00544	CbGeAlD
Tamoxifen—ESRRA—lymph node—sarcoma	0.000359	0.00536	CbGeAlD
Tamoxifen—ESR1—connective tissue—sarcoma	0.000357	0.00534	CbGeAlD
Tamoxifen—CYP1B1—smooth muscle tissue—sarcoma	0.000352	0.00525	CbGeAlD
Tamoxifen—CYP2C19—hematopoietic system—sarcoma	0.00035	0.00523	CbGeAlD
Tamoxifen—CYP1B1—skin of body—sarcoma	0.000347	0.00519	CbGeAlD
Tamoxifen—ABCG2—myometrium—sarcoma	0.000346	0.00517	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—liver—sarcoma	0.000345	0.00516	CbGeAlD
Tamoxifen—CES1—testis—sarcoma	0.000343	0.00512	CbGeAlD
Tamoxifen—ESR1—smooth muscle tissue—sarcoma	0.000327	0.00488	CbGeAlD
Tamoxifen—CES1—liver—sarcoma	0.000324	0.00484	CbGeAlD
Tamoxifen—CYP19A1—uterus—sarcoma	0.000323	0.00482	CbGeAlD
Tamoxifen—SIGMAR1—cardiac atrium—sarcoma	0.000319	0.00476	CbGeAlD
Tamoxifen—SIGMAR1—uterus—sarcoma	0.000317	0.00474	CbGeAlD
Tamoxifen—FMO3—lymph node—sarcoma	0.000315	0.00471	CbGeAlD
Tamoxifen—ABCG2—seminal vesicle—sarcoma	0.000313	0.00467	CbGeAlD
Tamoxifen—CYP2C8—hematopoietic system—sarcoma	0.000306	0.00457	CbGeAlD
Tamoxifen—CYP1B1—uterus—sarcoma	0.000302	0.00451	CbGeAlD
Tamoxifen—ESR2—testis—sarcoma	0.000297	0.00444	CbGeAlD
Tamoxifen—CYP1A2—hematopoietic system—sarcoma	0.000286	0.00428	CbGeAlD
Tamoxifen—CYP1A1—hematopoietic system—sarcoma	0.000282	0.00422	CbGeAlD
Tamoxifen—CYP2A6—liver—sarcoma	0.000282	0.00422	CbGeAlD
Tamoxifen—CYP1B1—lymphoid tissue—sarcoma	0.000281	0.0042	CbGeAlD
Tamoxifen—ESR2—liver—sarcoma	0.000281	0.0042	CbGeAlD
Tamoxifen—ESR1—uterus—sarcoma	0.00028	0.00419	CbGeAlD
Tamoxifen—SIGMAR1—tendon—sarcoma	0.000278	0.00415	CbGeAlD
Tamoxifen—CYP3A5—hematopoietic system—sarcoma	0.000276	0.00412	CbGeAlD
Tamoxifen—CYP2B6—hematopoietic system—sarcoma	0.000274	0.0041	CbGeAlD
Tamoxifen—CYP2C9—hematopoietic system—sarcoma	0.000272	0.00406	CbGeAlD
Tamoxifen—CYP2E1—seminal vesicle—sarcoma	0.000271	0.00405	CbGeAlD
Tamoxifen—ABCC2—tendon—sarcoma	0.00027	0.00403	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—sarcoma	0.000269	0.00402	CbGeAlD
Tamoxifen—CYP1B1—tendon—sarcoma	0.000264	0.00395	CbGeAlD
Tamoxifen—ESR1—lymphoid tissue—sarcoma	0.000261	0.0039	CbGeAlD
Tamoxifen—CYP2E1—hematopoietic system—sarcoma	0.000257	0.00385	CbGeAlD
Tamoxifen—CES1—lymph node—sarcoma	0.000249	0.00371	CbGeAlD
Tamoxifen—CYP1A1—skin of body—sarcoma	0.000245	0.00367	CbGeAlD
Tamoxifen—CYP2B6—skin of body—sarcoma	0.000238	0.00356	CbGeAlD
Tamoxifen—CYP19A1—testis—sarcoma	0.000234	0.0035	CbGeAlD
Tamoxifen—SIGMAR1—testis—sarcoma	0.00023	0.00344	CbGeAlD
Tamoxifen—ABCG2—uterus—sarcoma	0.000225	0.00336	CbGeAlD
Tamoxifen—ABCC2—testis—sarcoma	0.000223	0.00334	CbGeAlD
Tamoxifen—CYP19A1—liver—sarcoma	0.000221	0.00331	CbGeAlD
Tamoxifen—CYP1B1—testis—sarcoma	0.000219	0.00327	CbGeAlD
Tamoxifen—SIGMAR1—liver—sarcoma	0.000217	0.00325	CbGeAlD
Tamoxifen—ESR2—lymph node—sarcoma	0.000215	0.00322	CbGeAlD
Tamoxifen—CYP1A1—cardiac atrium—sarcoma	0.000214	0.0032	CbGeAlD
Tamoxifen—CYP1A1—uterus—sarcoma	0.000213	0.00319	CbGeAlD
Tamoxifen—ABCC2—liver—sarcoma	0.000211	0.00316	CbGeAlD
Tamoxifen—CYP3A4—hematopoietic system—sarcoma	0.000207	0.00309	CbGeAlD
Tamoxifen—CYP1B1—liver—sarcoma	0.000207	0.00309	CbGeAlD
Tamoxifen—CYP2D6—hematopoietic system—sarcoma	0.000204	0.00305	CbGeAlD
Tamoxifen—ESR1—testis—sarcoma	0.000203	0.00304	CbGeAlD
Tamoxifen—CYP2B6—lymphoid tissue—sarcoma	0.000193	0.00289	CbGeAlD
Tamoxifen—ESR1—liver—sarcoma	0.000192	0.00287	CbGeAlD
Tamoxifen—ABCG2—bone marrow—sarcoma	0.000191	0.00285	CbGeAlD
Tamoxifen—CYP2C19—liver—sarcoma	0.000181	0.00271	CbGeAlD
Tamoxifen—CYP2E1—lymphoid tissue—sarcoma	0.000181	0.00271	CbGeAlD
Tamoxifen—ABCB1—myometrium—sarcoma	0.000171	0.00255	CbGeAlD
Tamoxifen—CYP2E1—tendon—sarcoma	0.00017	0.00255	CbGeAlD
Tamoxifen—CYP19A1—lymph node—sarcoma	0.00017	0.00253	CbGeAlD
Tamoxifen—Dermatitis bullous—Epirubicin—sarcoma	0.000169	0.00121	CcSEcCtD
Tamoxifen—Fatigue—Dactinomycin—sarcoma	0.000169	0.00121	CcSEcCtD
Tamoxifen—Constipation—Thiotepa—sarcoma	0.000169	0.00121	CcSEcCtD
Tamoxifen—Pain—Thiotepa—sarcoma	0.000169	0.00121	CcSEcCtD
Tamoxifen—Back pain—Etoposide—sarcoma	0.000168	0.0012	CcSEcCtD
Tamoxifen—Pain—Dactinomycin—sarcoma	0.000168	0.0012	CcSEcCtD
Tamoxifen—CYP2C8—testis—sarcoma	0.000168	0.0025	CbGeAlD
Tamoxifen—Muscle spasms—Etoposide—sarcoma	0.000167	0.0012	CcSEcCtD
Tamoxifen—Thrombocytopenia—Mitoxantrone—sarcoma	0.000167	0.0012	CcSEcCtD
Tamoxifen—Anorexia—Vincristine—sarcoma	0.000167	0.0012	CcSEcCtD
Tamoxifen—SIGMAR1—lymph node—sarcoma	0.000167	0.00249	CbGeAlD
Tamoxifen—Hepatic failure—Doxorubicin—sarcoma	0.000167	0.00119	CcSEcCtD
Tamoxifen—Hyperhidrosis—Mitoxantrone—sarcoma	0.000165	0.00118	CcSEcCtD
Tamoxifen—ABCB1—embryo—sarcoma	0.000164	0.00245	CbGeAlD
Tamoxifen—ABCG2—testis—sarcoma	0.000163	0.00243	CbGeAlD
Tamoxifen—Anorexia—Mitoxantrone—sarcoma	0.000163	0.00116	CcSEcCtD
Tamoxifen—Osteoarthritis—Epirubicin—sarcoma	0.000162	0.00116	CcSEcCtD
Tamoxifen—ABCC2—lymph node—sarcoma	0.000162	0.00242	CbGeAlD
Tamoxifen—Gastrointestinal pain—Thiotepa—sarcoma	0.000162	0.00116	CcSEcCtD
Tamoxifen—Anaemia—Etoposide—sarcoma	0.000161	0.00115	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dactinomycin—sarcoma	0.00016	0.00115	CcSEcCtD
Tamoxifen—Hot flush—Doxorubicin—sarcoma	0.00016	0.00115	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Vincristine—sarcoma	0.00016	0.00114	CcSEcCtD
Tamoxifen—Menopausal symptoms—Doxorubicin—sarcoma	0.000159	0.00114	CcSEcCtD
Tamoxifen—CYP1B1—lymph node—sarcoma	0.000159	0.00237	CbGeAlD
Tamoxifen—Insomnia—Vincristine—sarcoma	0.000159	0.00114	CcSEcCtD
Tamoxifen—CYP2C8—liver—sarcoma	0.000158	0.00237	CbGeAlD
Tamoxifen—Paraesthesia—Vincristine—sarcoma	0.000157	0.00113	CcSEcCtD
Tamoxifen—Urticaria—Thiotepa—sarcoma	0.000157	0.00112	CcSEcCtD
Tamoxifen—Dermatitis bullous—Doxorubicin—sarcoma	0.000157	0.00112	CcSEcCtD
Tamoxifen—Abdominal pain—Thiotepa—sarcoma	0.000156	0.00112	CcSEcCtD
Tamoxifen—Leukopenia—Etoposide—sarcoma	0.000156	0.00111	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000156	0.00111	CcSEcCtD
Tamoxifen—Abdominal pain—Dactinomycin—sarcoma	0.000155	0.00111	CcSEcCtD
Tamoxifen—ABCB1—seminal vesicle—sarcoma	0.000154	0.0023	CbGeAlD
Tamoxifen—ABCG2—liver—sarcoma	0.000154	0.0023	CbGeAlD
Tamoxifen—Mood swings—Epirubicin—sarcoma	0.000153	0.0011	CcSEcCtD
Tamoxifen—Paraesthesia—Mitoxantrone—sarcoma	0.000153	0.0011	CcSEcCtD
Tamoxifen—Decreased appetite—Vincristine—sarcoma	0.000152	0.00109	CcSEcCtD
Tamoxifen—Dyspnoea—Mitoxantrone—sarcoma	0.000152	0.00109	CcSEcCtD
Tamoxifen—Cough—Etoposide—sarcoma	0.000152	0.00109	CcSEcCtD
Tamoxifen—Blood creatinine increased—Epirubicin—sarcoma	0.000152	0.00109	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Vincristine—sarcoma	0.000151	0.00108	CcSEcCtD
Tamoxifen—Fatigue—Vincristine—sarcoma	0.000151	0.00108	CcSEcCtD
Tamoxifen—CYP2B6—testis—sarcoma	0.00015	0.00225	CbGeAlD
Tamoxifen—Dyspepsia—Mitoxantrone—sarcoma	0.00015	0.00108	CcSEcCtD
Tamoxifen—Hypertension—Etoposide—sarcoma	0.00015	0.00108	CcSEcCtD
Tamoxifen—Constipation—Vincristine—sarcoma	0.00015	0.00107	CcSEcCtD
Tamoxifen—Pain—Vincristine—sarcoma	0.00015	0.00107	CcSEcCtD
Tamoxifen—Osteoarthritis—Doxorubicin—sarcoma	0.00015	0.00107	CcSEcCtD
Tamoxifen—Liver function test abnormal—Epirubicin—sarcoma	0.00015	0.00107	CcSEcCtD
Tamoxifen—Decreased appetite—Mitoxantrone—sarcoma	0.000148	0.00106	CcSEcCtD
Tamoxifen—CYP1A2—liver—sarcoma	0.000148	0.00221	CbGeAlD
Tamoxifen—Chest pain—Etoposide—sarcoma	0.000148	0.00106	CcSEcCtD
Tamoxifen—ESR1—lymph node—sarcoma	0.000147	0.0022	CbGeAlD
Tamoxifen—Fatigue—Mitoxantrone—sarcoma	0.000147	0.00105	CcSEcCtD
Tamoxifen—ABCB1—hematopoietic system—sarcoma	0.000147	0.00219	CbGeAlD
Tamoxifen—Discomfort—Etoposide—sarcoma	0.000146	0.00105	CcSEcCtD
Tamoxifen—CYP1A1—liver—sarcoma	0.000146	0.00218	CbGeAlD
Tamoxifen—Constipation—Mitoxantrone—sarcoma	0.000146	0.00105	CcSEcCtD
Tamoxifen—Pain—Mitoxantrone—sarcoma	0.000146	0.00105	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000146	0.00104	CcSEcCtD
Tamoxifen—Hypersensitivity—Thiotepa—sarcoma	0.000146	0.00104	CcSEcCtD
Tamoxifen—Hypersensitivity—Dactinomycin—sarcoma	0.000145	0.00103	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Vincristine—sarcoma	0.000143	0.00103	CcSEcCtD
Tamoxifen—CYP3A5—liver—sarcoma	0.000143	0.00214	CbGeAlD
Tamoxifen—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000143	0.00102	CcSEcCtD
Tamoxifen—CYP2B6—liver—sarcoma	0.000142	0.00212	CbGeAlD
Tamoxifen—Mood swings—Doxorubicin—sarcoma	0.000142	0.00102	CcSEcCtD
Tamoxifen—Asthenia—Thiotepa—sarcoma	0.000142	0.00102	CcSEcCtD
Tamoxifen—Infection—Etoposide—sarcoma	0.000141	0.00101	CcSEcCtD
Tamoxifen—CYP2E1—testis—sarcoma	0.000141	0.00211	CbGeAlD
Tamoxifen—Asthenia—Dactinomycin—sarcoma	0.000141	0.00101	CcSEcCtD
Tamoxifen—CYP2C9—liver—sarcoma	0.000141	0.0021	CbGeAlD
Tamoxifen—Blood creatinine increased—Doxorubicin—sarcoma	0.00014	0.00101	CcSEcCtD
Tamoxifen—Influenza—Epirubicin—sarcoma	0.00014	0.001	CcSEcCtD
Tamoxifen—Dysphagia—Epirubicin—sarcoma	0.00014	0.001	CcSEcCtD
Tamoxifen—Pruritus—Thiotepa—sarcoma	0.00014	0.001	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00014	0.000999	CcSEcCtD
Tamoxifen—Thrombocytopenia—Etoposide—sarcoma	0.000139	0.000995	CcSEcCtD
Tamoxifen—Abdominal pain—Vincristine—sarcoma	0.000139	0.000992	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—sarcoma	0.000138	0.00099	CcSEcCtD
Tamoxifen—Hyperhidrosis—Etoposide—sarcoma	0.000137	0.000983	CcSEcCtD
Tamoxifen—Pancreatitis—Epirubicin—sarcoma	0.000137	0.000982	CcSEcCtD
Tamoxifen—Angina pectoris—Epirubicin—sarcoma	0.000136	0.000976	CcSEcCtD
Tamoxifen—Urticaria—Mitoxantrone—sarcoma	0.000136	0.000971	CcSEcCtD
Tamoxifen—Anorexia—Etoposide—sarcoma	0.000135	0.000969	CcSEcCtD
Tamoxifen—Diarrhoea—Thiotepa—sarcoma	0.000135	0.000968	CcSEcCtD
Tamoxifen—Abdominal pain—Mitoxantrone—sarcoma	0.000135	0.000966	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000135	0.000966	CcSEcCtD
Tamoxifen—Bronchitis—Epirubicin—sarcoma	0.000135	0.000964	CcSEcCtD
Tamoxifen—Diarrhoea—Dactinomycin—sarcoma	0.000134	0.000961	CcSEcCtD
Tamoxifen—CYP2E1—liver—sarcoma	0.000133	0.00199	CbGeAlD
Tamoxifen—Pancytopenia—Epirubicin—sarcoma	0.000133	0.000952	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000132	0.000946	CcSEcCtD
Tamoxifen—Neutropenia—Epirubicin—sarcoma	0.000131	0.000937	CcSEcCtD
Tamoxifen—Dizziness—Thiotepa—sarcoma	0.000131	0.000936	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—sarcoma	0.000129	0.000927	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—sarcoma	0.000129	0.000927	CcSEcCtD
Tamoxifen—Hypersensitivity—Vincristine—sarcoma	0.000129	0.000925	CcSEcCtD
Tamoxifen—Paraesthesia—Etoposide—sarcoma	0.000127	0.000913	CcSEcCtD
Tamoxifen—Weight increased—Epirubicin—sarcoma	0.000127	0.000912	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—sarcoma	0.000127	0.000909	CcSEcCtD
Tamoxifen—Weight decreased—Epirubicin—sarcoma	0.000127	0.000907	CcSEcCtD
Tamoxifen—Dyspnoea—Etoposide—sarcoma	0.000127	0.000906	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—sarcoma	0.000126	0.000903	CcSEcCtD
Tamoxifen—Hypersensitivity—Mitoxantrone—sarcoma	0.000126	0.0009	CcSEcCtD
Tamoxifen—Asthenia—Vincristine—sarcoma	0.000126	0.0009	CcSEcCtD
Tamoxifen—Vomiting—Thiotepa—sarcoma	0.000126	0.0009	CcSEcCtD
Tamoxifen—Pneumonia—Epirubicin—sarcoma	0.000126	0.000899	CcSEcCtD
Tamoxifen—Vomiting—Dactinomycin—sarcoma	0.000125	0.000893	CcSEcCtD
Tamoxifen—Rash—Thiotepa—sarcoma	0.000125	0.000892	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—sarcoma	0.000125	0.000892	CcSEcCtD
Tamoxifen—Dermatitis—Thiotepa—sarcoma	0.000125	0.000891	CcSEcCtD
Tamoxifen—Headache—Thiotepa—sarcoma	0.000124	0.000887	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000124	0.000886	CcSEcCtD
Tamoxifen—Rash—Dactinomycin—sarcoma	0.000124	0.000886	CcSEcCtD
Tamoxifen—Decreased appetite—Etoposide—sarcoma	0.000123	0.000884	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—sarcoma	0.000123	0.000881	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Etoposide—sarcoma	0.000123	0.000878	CcSEcCtD
Tamoxifen—Asthenia—Mitoxantrone—sarcoma	0.000122	0.000877	CcSEcCtD
Tamoxifen—Fatigue—Etoposide—sarcoma	0.000122	0.000876	CcSEcCtD
Tamoxifen—Pain—Etoposide—sarcoma	0.000121	0.000869	CcSEcCtD
Tamoxifen—Constipation—Etoposide—sarcoma	0.000121	0.000869	CcSEcCtD
Tamoxifen—Urinary tract infection—Epirubicin—sarcoma	0.000121	0.000868	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—sarcoma	0.000121	0.000867	CcSEcCtD
Tamoxifen—Diarrhoea—Vincristine—sarcoma	0.00012	0.000859	CcSEcCtD
Tamoxifen—Sweating—Epirubicin—sarcoma	0.00012	0.000857	CcSEcCtD
Tamoxifen—ABCG2—lymph node—sarcoma	0.000118	0.00176	CbGeAlD
Tamoxifen—Weight increased—Doxorubicin—sarcoma	0.000118	0.000844	CcSEcCtD
Tamoxifen—Nausea—Thiotepa—sarcoma	0.000117	0.000841	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—sarcoma	0.000117	0.000839	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—sarcoma	0.000117	0.000838	CcSEcCtD
Tamoxifen—Diarrhoea—Mitoxantrone—sarcoma	0.000117	0.000836	CcSEcCtD
Tamoxifen—Nausea—Dactinomycin—sarcoma	0.000117	0.000834	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—sarcoma	0.000116	0.000832	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Etoposide—sarcoma	0.000116	0.000831	CcSEcCtD
Tamoxifen—Dizziness—Vincristine—sarcoma	0.000116	0.00083	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000114	0.00082	CcSEcCtD
Tamoxifen—Urticaria—Etoposide—sarcoma	0.000113	0.000808	CcSEcCtD
Tamoxifen—Haemoglobin—Epirubicin—sarcoma	0.000113	0.000806	CcSEcCtD
Tamoxifen—Abdominal pain—Etoposide—sarcoma	0.000112	0.000804	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—sarcoma	0.000112	0.000804	CcSEcCtD
Tamoxifen—CYP1A1—lymph node—sarcoma	0.000112	0.00168	CbGeAlD
Tamoxifen—Haemorrhage—Epirubicin—sarcoma	0.000112	0.000802	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—sarcoma	0.000112	0.000802	CcSEcCtD
Tamoxifen—CYP2D6—testis—sarcoma	0.000112	0.00167	CbGeAlD
Tamoxifen—Hypoaesthesia—Epirubicin—sarcoma	0.000111	0.000798	CcSEcCtD
Tamoxifen—Vomiting—Vincristine—sarcoma	0.000111	0.000798	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—sarcoma	0.000111	0.000796	CcSEcCtD
Tamoxifen—ABCB1—uterus—sarcoma	0.000111	0.00165	CbGeAlD
Tamoxifen—Sweating—Doxorubicin—sarcoma	0.000111	0.000793	CcSEcCtD
Tamoxifen—Rash—Vincristine—sarcoma	0.000111	0.000791	CcSEcCtD
Tamoxifen—Dermatitis—Vincristine—sarcoma	0.00011	0.000791	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—sarcoma	0.00011	0.00079	CcSEcCtD
Tamoxifen—Headache—Vincristine—sarcoma	0.00011	0.000786	CcSEcCtD
Tamoxifen—Vomiting—Mitoxantrone—sarcoma	0.000109	0.000777	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—sarcoma	0.000108	0.000776	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—sarcoma	0.000108	0.000773	CcSEcCtD
Tamoxifen—Rash—Mitoxantrone—sarcoma	0.000108	0.000771	CcSEcCtD
Tamoxifen—Dermatitis—Mitoxantrone—sarcoma	0.000108	0.00077	CcSEcCtD
Tamoxifen—CYP3A4—liver—sarcoma	0.000107	0.0016	CbGeAlD
Tamoxifen—Headache—Mitoxantrone—sarcoma	0.000107	0.000766	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—sarcoma	0.000106	0.000758	CcSEcCtD
Tamoxifen—CYP2D6—liver—sarcoma	0.000106	0.00158	CbGeAlD
Tamoxifen—Hypersensitivity—Etoposide—sarcoma	0.000105	0.000749	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—sarcoma	0.000104	0.000746	CcSEcCtD
Tamoxifen—Nausea—Vincristine—sarcoma	0.000104	0.000745	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—sarcoma	0.000104	0.000744	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—sarcoma	0.000104	0.000742	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—sarcoma	0.000104	0.000742	CcSEcCtD
Tamoxifen—ABCB1—lymphoid tissue—sarcoma	0.000103	0.00154	CbGeAlD
Tamoxifen—Hypoaesthesia—Doxorubicin—sarcoma	0.000103	0.000738	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—sarcoma	0.000103	0.000737	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—sarcoma	0.000102	0.000731	CcSEcCtD
Tamoxifen—Asthenia—Etoposide—sarcoma	0.000102	0.000729	CcSEcCtD
Tamoxifen—Nausea—Mitoxantrone—sarcoma	0.000101	0.000726	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—sarcoma	0.0001	0.000719	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—sarcoma	0.0001	0.000717	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—sarcoma	9.99e-05	0.000715	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—sarcoma	9.9e-05	0.000709	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—sarcoma	9.8e-05	0.000702	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—sarcoma	9.75e-05	0.000698	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—sarcoma	9.71e-05	0.000696	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—sarcoma	9.62e-05	0.000689	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—sarcoma	9.55e-05	0.000684	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—sarcoma	9.43e-05	0.000675	CcSEcCtD
Tamoxifen—ABCB1—bone marrow—sarcoma	9.4e-05	0.0014	CbGeAlD
Tamoxifen—Dizziness—Etoposide—sarcoma	9.39e-05	0.000672	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—sarcoma	9.38e-05	0.000671	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—sarcoma	9.26e-05	0.000663	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—sarcoma	9.16e-05	0.000656	CcSEcCtD
Tamoxifen—Vomiting—Etoposide—sarcoma	9.03e-05	0.000646	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—sarcoma	9.02e-05	0.000646	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—sarcoma	9.01e-05	0.000645	CcSEcCtD
Tamoxifen—Rash—Etoposide—sarcoma	8.95e-05	0.000641	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—sarcoma	8.94e-05	0.00064	CcSEcCtD
Tamoxifen—Headache—Etoposide—sarcoma	8.89e-05	0.000637	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—sarcoma	8.84e-05	0.000633	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—sarcoma	8.73e-05	0.000625	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—sarcoma	8.73e-05	0.000625	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—sarcoma	8.68e-05	0.000621	CcSEcCtD
Tamoxifen—Cough—Epirubicin—sarcoma	8.51e-05	0.000609	CcSEcCtD
Tamoxifen—Nausea—Etoposide—sarcoma	8.43e-05	0.000604	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—sarcoma	8.42e-05	0.000603	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—sarcoma	8.34e-05	0.000597	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—sarcoma	8.3e-05	0.000594	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—sarcoma	8.3e-05	0.000594	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—sarcoma	8.3e-05	0.000594	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—sarcoma	8.27e-05	0.000592	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—sarcoma	8.2e-05	0.000587	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—sarcoma	8.12e-05	0.000581	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—sarcoma	8.08e-05	0.000578	CcSEcCtD
Tamoxifen—ABCB1—testis—sarcoma	8.03e-05	0.0012	CbGeAlD
Tamoxifen—Oedema—Epirubicin—sarcoma	7.96e-05	0.00057	CcSEcCtD
Tamoxifen—Infection—Epirubicin—sarcoma	7.91e-05	0.000566	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—sarcoma	7.87e-05	0.000564	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—sarcoma	7.79e-05	0.000558	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—sarcoma	7.79e-05	0.000558	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—sarcoma	7.69e-05	0.000551	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—sarcoma	7.68e-05	0.00055	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—sarcoma	7.68e-05	0.00055	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—sarcoma	7.68e-05	0.00055	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—sarcoma	7.66e-05	0.000548	CcSEcCtD
Tamoxifen—ABCB1—liver—sarcoma	7.59e-05	0.00113	CbGeAlD
Tamoxifen—Discomfort—Doxorubicin—sarcoma	7.59e-05	0.000543	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—sarcoma	7.59e-05	0.000543	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—sarcoma	7.51e-05	0.000538	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—sarcoma	7.36e-05	0.000527	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—sarcoma	7.32e-05	0.000524	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—sarcoma	7.25e-05	0.000519	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—sarcoma	7.21e-05	0.000516	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—sarcoma	7.2e-05	0.000515	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—sarcoma	7.15e-05	0.000512	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—sarcoma	7.12e-05	0.00051	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—sarcoma	7.1e-05	0.000508	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—sarcoma	7.02e-05	0.000503	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—sarcoma	7.01e-05	0.000502	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—sarcoma	6.92e-05	0.000495	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—sarcoma	6.87e-05	0.000492	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—sarcoma	6.86e-05	0.000491	CcSEcCtD
Tamoxifen—Pain—Epirubicin—sarcoma	6.81e-05	0.000487	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—sarcoma	6.81e-05	0.000487	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.71e-05	0.00048	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—sarcoma	6.66e-05	0.000477	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—sarcoma	6.61e-05	0.000473	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—sarcoma	6.57e-05	0.00047	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—sarcoma	6.51e-05	0.000466	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—sarcoma	6.48e-05	0.000464	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—sarcoma	6.4e-05	0.000458	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—sarcoma	6.36e-05	0.000455	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—sarcoma	6.35e-05	0.000455	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—sarcoma	6.32e-05	0.000453	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—sarcoma	6.3e-05	0.000451	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—sarcoma	6.3e-05	0.000451	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—sarcoma	6.29e-05	0.00045	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—sarcoma	6.02e-05	0.000431	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—sarcoma	5.86e-05	0.00042	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—sarcoma	5.85e-05	0.000419	CcSEcCtD
Tamoxifen—ABCB1—lymph node—sarcoma	5.82e-05	0.00087	CbGeAlD
Tamoxifen—Abdominal pain—Doxorubicin—sarcoma	5.82e-05	0.000417	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—sarcoma	5.71e-05	0.000409	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—sarcoma	5.63e-05	0.000403	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—sarcoma	5.45e-05	0.00039	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—sarcoma	5.43e-05	0.000388	CcSEcCtD
Tamoxifen—ESR1—LKB1 signaling events—MYC—sarcoma	5.31e-05	0.00224	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	5.3e-05	0.00223	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	5.3e-05	0.00223	CbGpPWpGaD
Tamoxifen—Asthenia—Doxorubicin—sarcoma	5.28e-05	0.000378	CcSEcCtD
Tamoxifen—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	5.28e-05	0.00222	CbGpPWpGaD
Tamoxifen—Dizziness—Epirubicin—sarcoma	5.26e-05	0.000377	CcSEcCtD
Tamoxifen—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	5.23e-05	0.0022	CbGpPWpGaD
Tamoxifen—Pruritus—Doxorubicin—sarcoma	5.21e-05	0.000373	CcSEcCtD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	5.18e-05	0.00218	CbGpPWpGaD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	5.15e-05	0.00217	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	5.14e-05	0.00216	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—JUN—sarcoma	5.13e-05	0.00216	CbGpPWpGaD
Tamoxifen—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	5.1e-05	0.00215	CbGpPWpGaD
Tamoxifen—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	5.06e-05	0.00213	CbGpPWpGaD
Tamoxifen—Vomiting—Epirubicin—sarcoma	5.06e-05	0.000362	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—sarcoma	5.04e-05	0.000361	CcSEcCtD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	5.03e-05	0.00212	CbGpPWpGaD
Tamoxifen—Rash—Epirubicin—sarcoma	5.02e-05	0.000359	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—sarcoma	5.01e-05	0.000359	CcSEcCtD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	5e-05	0.00211	CbGpPWpGaD
Tamoxifen—Headache—Epirubicin—sarcoma	4.99e-05	0.000357	CcSEcCtD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—VEGFA—sarcoma	4.94e-05	0.00208	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	4.92e-05	0.00207	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—ENO2—sarcoma	4.88e-05	0.00206	CbGpPWpGaD
Tamoxifen—Dizziness—Doxorubicin—sarcoma	4.87e-05	0.000349	CcSEcCtD
Tamoxifen—DHCR7—Metabolism—HBA1—sarcoma	4.85e-05	0.00204	CbGpPWpGaD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	4.82e-05	0.00203	CbGpPWpGaD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	4.81e-05	0.00202	CbGpPWpGaD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—TP53—sarcoma	4.79e-05	0.00202	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—ENO2—sarcoma	4.79e-05	0.00202	CbGpPWpGaD
Tamoxifen—CYP1A1—Tryptophan metabolism—MDM2—sarcoma	4.77e-05	0.00201	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—HBA1—sarcoma	4.76e-05	0.002	CbGpPWpGaD
Tamoxifen—Nausea—Epirubicin—sarcoma	4.73e-05	0.000338	CcSEcCtD
Tamoxifen—ESR1—Regulation of Telomerase—IL2—sarcoma	4.71e-05	0.00198	CbGpPWpGaD
Tamoxifen—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	4.68e-05	0.00197	CbGpPWpGaD
Tamoxifen—Vomiting—Doxorubicin—sarcoma	4.68e-05	0.000335	CcSEcCtD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—JUN—sarcoma	4.68e-05	0.00197	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	4.65e-05	0.00196	CbGpPWpGaD
Tamoxifen—Rash—Doxorubicin—sarcoma	4.64e-05	0.000332	CcSEcCtD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	4.64e-05	0.00195	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	4.64e-05	0.00195	CbGpPWpGaD
Tamoxifen—Dermatitis—Doxorubicin—sarcoma	4.64e-05	0.000332	CcSEcCtD
Tamoxifen—EBP—Metabolism—ENO2—sarcoma	4.63e-05	0.00195	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FOXO1—sarcoma	4.62e-05	0.00194	CbGpPWpGaD
Tamoxifen—Headache—Doxorubicin—sarcoma	4.61e-05	0.00033	CcSEcCtD
Tamoxifen—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	4.61e-05	0.00194	CbGpPWpGaD
Tamoxifen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	4.6e-05	0.00194	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—IL2—sarcoma	4.6e-05	0.00194	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—HBA1—sarcoma	4.6e-05	0.00194	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	4.59e-05	0.00193	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—CCND1—sarcoma	4.59e-05	0.00193	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—JUN—sarcoma	4.58e-05	0.00193	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	4.58e-05	0.00193	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	4.54e-05	0.00191	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—CCND1—sarcoma	4.49e-05	0.00189	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—JUN—sarcoma	4.48e-05	0.00188	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	4.44e-05	0.00187	CbGpPWpGaD
Tamoxifen—Nausea—Doxorubicin—sarcoma	4.37e-05	0.000313	CcSEcCtD
Tamoxifen—ESR1—LKB1 signaling events—TP53—sarcoma	4.36e-05	0.00184	CbGpPWpGaD
Tamoxifen—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	4.34e-05	0.00182	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	4.27e-05	0.00179	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	4.25e-05	0.00179	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—CCND1—sarcoma	4.25e-05	0.00179	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	4.15e-05	0.00175	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PLCG1—sarcoma	4.14e-05	0.00174	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—VEGFA—sarcoma	4.09e-05	0.00172	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PLCG1—sarcoma	4.07e-05	0.00171	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—PDGFRA—sarcoma	4.05e-05	0.0017	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4.01e-05	0.00169	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.99e-05	0.00168	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	3.98e-05	0.00168	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ENO2—sarcoma	3.98e-05	0.00168	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.98e-05	0.00167	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—HBA1—sarcoma	3.96e-05	0.00166	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.95e-05	0.00166	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.95e-05	0.00166	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PLCG1—sarcoma	3.93e-05	0.00165	CbGpPWpGaD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	3.87e-05	0.00163	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—SRC—sarcoma	3.8e-05	0.0016	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.78e-05	0.00159	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	3.77e-05	0.00159	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CREB1—sarcoma	3.76e-05	0.00158	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	3.72e-05	0.00157	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—SRC—sarcoma	3.72e-05	0.00157	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ENO2—sarcoma	3.7e-05	0.00156	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—MYC—sarcoma	3.68e-05	0.00155	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—HBA1—sarcoma	3.68e-05	0.00155	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	3.62e-05	0.00153	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—EGFR—sarcoma	3.6e-05	0.00152	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—MYC—sarcoma	3.6e-05	0.00151	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	3.58e-05	0.00151	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.57e-05	0.0015	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—KIT—sarcoma	3.52e-05	0.00148	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.47e-05	0.00146	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	3.45e-05	0.00145	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PLCG1—sarcoma	3.38e-05	0.00142	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	3.37e-05	0.00142	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—CREB1—sarcoma	3.35e-05	0.00141	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—MYC—sarcoma	3.34e-05	0.0014	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	3.26e-05	0.00137	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	3.26e-05	0.00137	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	3.2e-05	0.00135	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.2e-05	0.00135	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PLCG1—sarcoma	3.14e-05	0.00132	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.13e-05	0.00132	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	3.11e-05	0.00131	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.08e-05	0.0013	CbGpPWpGaD
Tamoxifen—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	3.04e-05	0.00128	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—FUS—sarcoma	2.96e-05	0.00125	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—sarcoma	2.96e-05	0.00124	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.95e-05	0.00124	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ENO2—sarcoma	2.85e-05	0.0012	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—HBA1—sarcoma	2.83e-05	0.00119	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.79e-05	0.00117	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	2.78e-05	0.00117	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—MDM2—sarcoma	2.77e-05	0.00117	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	2.72e-05	0.00114	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	2.71e-05	0.00114	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	2.7e-05	0.00114	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	2.68e-05	0.00113	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—HRAS—sarcoma	2.67e-05	0.00113	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	2.65e-05	0.00111	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.63e-05	0.0011	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.62e-05	0.0011	CbGpPWpGaD
Tamoxifen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	2.53e-05	0.00107	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—MYC—sarcoma	2.5e-05	0.00105	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	2.48e-05	0.00104	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	2.43e-05	0.00102	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	2.42e-05	0.00102	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PLCG1—sarcoma	2.41e-05	0.00102	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	2.4e-05	0.00101	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ENO2—sarcoma	2.38e-05	0.001	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	2.37e-05	0.000999	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	2.37e-05	0.000999	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—HBA1—sarcoma	2.37e-05	0.000997	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	2.36e-05	0.000994	CbGpPWpGaD
Tamoxifen—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	2.35e-05	0.000989	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	2.31e-05	0.000973	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.31e-05	0.000971	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	2.28e-05	0.000961	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—IL2—sarcoma	2.21e-05	0.00093	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	2.17e-05	0.000914	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.17e-05	0.000913	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	2.13e-05	0.000895	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	2.13e-05	0.000894	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	2.11e-05	0.00089	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	2.08e-05	0.000875	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	2.08e-05	0.000875	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—NRAS—sarcoma	2.08e-05	0.000874	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PLCG1—sarcoma	2.02e-05	0.000852	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.01e-05	0.000846	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	2.01e-05	0.000845	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.01e-05	0.000844	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2e-05	0.000841	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.99e-05	0.000838	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	1.96e-05	0.000827	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	1.95e-05	0.000819	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	1.9e-05	0.000801	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—EGFR—sarcoma	1.89e-05	0.000797	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—VEGFA—sarcoma	1.88e-05	0.00079	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.8e-05	0.000757	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	1.8e-05	0.000756	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—KRAS—sarcoma	1.79e-05	0.000752	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	1.78e-05	0.000751	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ENO2—sarcoma	1.76e-05	0.00074	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.75e-05	0.000737	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—HBA1—sarcoma	1.75e-05	0.000735	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	1.67e-05	0.000703	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.61e-05	0.000678	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	1.6e-05	0.000672	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—MYC—sarcoma	1.59e-05	0.000668	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.58e-05	0.000664	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—HRAS—sarcoma	1.52e-05	0.00064	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PLCG1—sarcoma	1.49e-05	0.000628	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.49e-05	0.000627	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.48e-05	0.000621	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ENO2—sarcoma	1.33e-05	0.000558	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.32e-05	0.000557	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—HBA1—sarcoma	1.32e-05	0.000555	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ENO2—sarcoma	1.28e-05	0.000538	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TLE1—sarcoma	1.27e-05	0.000535	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—HBA1—sarcoma	1.27e-05	0.000534	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.22e-05	0.000514	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MYC—sarcoma	1.2e-05	0.000506	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ENO2—sarcoma	1.16e-05	0.000489	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—HBA1—sarcoma	1.15e-05	0.000486	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ENO2—sarcoma	1.15e-05	0.000485	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—HBA1—sarcoma	1.14e-05	0.000482	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PLCG1—sarcoma	1.13e-05	0.000474	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PLCG1—sarcoma	1.08e-05	0.000456	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFC—sarcoma	1.07e-05	0.000451	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.06e-05	0.000447	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.06e-05	0.000447	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ENO2—sarcoma	1.06e-05	0.000444	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.05e-05	0.000443	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—HBA1—sarcoma	1.05e-05	0.000442	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PLCG1—sarcoma	9.86e-06	0.000415	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PLCG1—sarcoma	9.77e-06	0.000411	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	9.52e-06	0.000401	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	9.27e-06	0.00039	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PLCG1—sarcoma	8.96e-06	0.000377	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FLT1—sarcoma	8.57e-06	0.000361	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	8.53e-06	0.000359	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ENO2—sarcoma	8.52e-06	0.000359	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—HBA1—sarcoma	8.47e-06	0.000356	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PLCG1—sarcoma	8.43e-06	0.000355	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ENO2—sarcoma	8.34e-06	0.000351	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	8.34e-06	0.000351	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ENO2—sarcoma	8.33e-06	0.00035	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—HBA1—sarcoma	8.29e-06	0.000349	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—HBA1—sarcoma	8.27e-06	0.000348	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCR4—sarcoma	8.1e-06	0.000341	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MYC—sarcoma	8.01e-06	0.000337	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ATF1—sarcoma	8e-06	0.000337	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	7.88e-06	0.000332	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ENO2—sarcoma	7.87e-06	0.000331	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—HBA1—sarcoma	7.82e-06	0.000329	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MYC—sarcoma	7.65e-06	0.000322	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PLCG1—sarcoma	7.23e-06	0.000304	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ENO2—sarcoma	7.21e-06	0.000304	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HBA1—sarcoma	7.17e-06	0.000302	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PLCG1—sarcoma	7.08e-06	0.000298	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PLCG1—sarcoma	7.07e-06	0.000297	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	7e-06	0.000295	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PLCG1—sarcoma	6.68e-06	0.000281	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO2—sarcoma	6.44e-06	0.000271	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HBA1—sarcoma	6.4e-06	0.000269	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO2—sarcoma	6.28e-06	0.000264	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1R—sarcoma	6.28e-06	0.000264	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HBA1—sarcoma	6.24e-06	0.000263	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PLCG1—sarcoma	6.12e-06	0.000258	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FOXO1—sarcoma	5.98e-06	0.000252	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PDGFRB—sarcoma	5.97e-06	0.000251	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO2—sarcoma	5.92e-06	0.000249	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HBA1—sarcoma	5.88e-06	0.000248	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PDGFRA—sarcoma	5.88e-06	0.000247	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO2—sarcoma	5.87e-06	0.000247	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HBA1—sarcoma	5.83e-06	0.000245	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PLCG1—sarcoma	5.46e-06	0.00023	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLCG1—sarcoma	5.33e-06	0.000224	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLCG1—sarcoma	5.02e-06	0.000211	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO2—sarcoma	5.02e-06	0.000211	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HBA1—sarcoma	4.98e-06	0.00021	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLCG1—sarcoma	4.98e-06	0.00021	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—sarcoma	4.95e-06	0.000208	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KIT—sarcoma	4.56e-06	0.000192	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CREB1—sarcoma	4.34e-06	0.000182	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLCG1—sarcoma	4.26e-06	0.000179	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—sarcoma	3.87e-06	0.000163	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—sarcoma	3.86e-06	0.000162	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HBA1—sarcoma	3.85e-06	0.000162	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—sarcoma	3.59e-06	0.000151	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLCG1—sarcoma	3.28e-06	0.000138	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—sarcoma	3.21e-06	0.000135	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—sarcoma	3.13e-06	0.000132	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—sarcoma	3.12e-06	0.000131	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—sarcoma	3.09e-06	0.00013	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—sarcoma	2.8e-06	0.000118	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—sarcoma	2.72e-06	0.000115	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—sarcoma	2.69e-06	0.000113	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—sarcoma	2.51e-06	0.000105	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—sarcoma	2.45e-06	0.000103	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—sarcoma	2.32e-06	9.75e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—sarcoma	2.06e-06	8.66e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—sarcoma	1.97e-06	8.28e-05	CbGpPWpGaD
